Fundraising FoxAlphabiopharma
Shanghai, CN · 1 known investors
Find your way into Alphabiopharma
Sign up to see every warm intro you have to Alphabiopharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alphabiopharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company developing oncology treatments including EGFR-targeting small molecule drugs for lung cancer with CNS penetration, and expanding into cell immunotherapy through licensed partnerships for NK cell and CAR-T therapies targeting solid tumors and hematologic malignancies.
Investors · 1
Frequently asked questions
- What does Alphabiopharma do?
- A biopharmaceutical company developing oncology treatments including EGFR-targeting small molecule drugs for lung cancer with CNS penetration, and expanding into cell immunotherapy through licensed partnerships for NK cell and CAR-T therapies targeting solid tumors and hematologic malignancies.
- Who are Alphabiopharma's investors?
- Alphabiopharma's investors include LYZZ Capital.
- Where is Alphabiopharma headquartered?
- Alphabiopharma is headquartered in Shanghai, CN.